ArticleRSC chemical biology2022

Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration.

A Vogelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.